Your browser doesn't support javascript.
loading
Fluticasone propionate/salmeterol 250/50 µg versus salmeterol 50 µg after chronic obstructive pulmonary disease exacerbation.
Ohar, Jill A; Crater, Glenn D; Emmett, Amanda; Ferro, Thomas J; Morris, Andrea N; Raphiou, Ibrahim; Sriram, Peruvemba S; Dransfield, Mark T.
Affiliation
  • Ohar JA; Wake Forest University Medical Center, 1 Medical Center Boulevard, Winston-Salem, NC, USA. johar@wakehealth.edu.
Respir Res ; 15: 105, 2014 Sep 24.
Article in En | MEDLINE | ID: mdl-25248764
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Disease Progression / Pulmonary Disease, Chronic Obstructive / Albuterol / Androstadienes Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Respir Res Year: 2014 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Disease Progression / Pulmonary Disease, Chronic Obstructive / Albuterol / Androstadienes Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Respir Res Year: 2014 Document type: Article Affiliation country: Country of publication: